Purple Biotech Ltd
PPBT
$1.50
$0.010.33%
NASDAQ
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.11M | 9.57M | 5.92M | 7.09M | |
| Total Receivables | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | -- | 155.00K | -- | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | 485.00K | 137.00K | 394.00K | 428.00K | |
| Total Current Assets | 6.59M | 9.87M | 6.31M | 7.52M | |
|
|
|||||
| Total Current Assets | 6.59M | 9.87M | 6.31M | 7.52M | |
| Net Property, Plant & Equipment | 216.00K | 346.00K | 223.00K | 237.00K | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | 7.36M | 7.36M | 27.84M | 27.84M | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | -- | -- | -- | -- | |
| Total Assets | 14.17M | 17.57M | 34.38M | 35.59M | |
|
|
|||||
| Total Accounts Payable | 487.00K | 2.07M | 669.00K | 868.00K | |
| Total Accrued Expenses | 933.00K | 1.37M | 1.15M | 1.34M | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 134.00K | 244.00K | 103.00K | 137.00K | |
| Total Finance Division Other Current Liabilities | 229.00K | 4.07M | 267.00K | 411.00K | |
| Total Other Current Liabilities | 229.00K | 4.07M | 267.00K | 411.00K | |
| Total Current Liabilities | 1.78M | 7.75M | 2.19M | 2.76M | |
|
|
|||||
| Total Current Liabilities | 1.78M | 7.75M | 2.19M | 2.76M | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | 170.00K | 160.00K | 140.00K | 140.00K | |
| Total Liabilities | 1.95M | 7.91M | 2.33M | 2.90M | |
|
|
|||||
| Common Stock & APIC | 155.83M | 152.48M | 149.82M | 147.94M | |
| Retained Earnings | -170.72M | -171.08M | -146.23M | -145.15M | |
| Treasury Stock & Other | 27.16M | 28.31M | 28.41M | 29.86M | |
| Total Common Equity | 12.27M | 9.71M | 32.01M | 32.65M | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | 12.27M | 9.71M | 32.01M | 32.65M | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | -58.00K | -55.00K | 44.00K | 48.00K | |
| Total Equity | 12.21M | 9.66M | 32.05M | 32.70M | |
|
|
|||||